AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2018
Mar 15, 2018
31676_dirs_2018-03-14_66e0952d-0ecd-4625-beb9-f6f5aaf85ca8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-03-12
Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-12 | Common Stock | M | 15723 | $6.36 | Acquired | 225706 | Direct |
| 2018-03-13 | Common Stock | S | 23475 | $61.52 | Disposed | 202231 | Direct |
| 2018-03-13 | Common Stock | S | 6525 | $62.63 | Disposed | 195706 | Direct |
| 2018-03-14 | Common Stock | S | 10000 | $62.03 | Disposed | 185706 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-12 | Stock Option | $6.36 | M | 15723 | Disposed | 2023-07-11 | Common Stock (15723) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $61.11 to $62.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $62.12 to $63.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $62.00 to $62.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: The options vested and become exercisable in equal annual amounts over a four-year period beginning on the first anniversary of the grant date. The grant date was July 12, 2013.